Beta-caryophyllene Protects Against Alcoholic Steatohepatitis By Attenuating Inflammation And Metabolic Dysregulation In Mice

Fatty Liver Disease (non-alcoholic) aka (Steatosis)

Key Findings

Given the safety of BCP in humans this food additive has a high translational potential in treating or preventing hepatic injury associated with oxidative stress, inflammation and steatosis.

Information and Links


Link: Beta-caryophyllene Protects Against Alcoholic Steatohepatitis By Attenuating Inflammation And Metabolic Dysregulation In Mice

Year: 2017

DOI: 10.1111/bph.13722


Ratings

(How Ratings Work)

Fatty Liver Disease (non-alcoholic) aka (Steatosis) — 2


Possible to probable range of efficacy of cannabis for treatment of Fatty Liver Disease (non-alcoholic) aka (Steatosis) according to the results found in this study.

Drugs Used

Beta-caryophyllene